CD22 Positive
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What CD22 Positive Means in Everyday Medical Language
CD22 positive means that certain cells have a protein called CD22 on their surface. This protein is mostly found on B cells, which are a type of white blood cell that helps your immune system fight infections. CD22 plays a role in how these cells send signals, stick to other cells, grow, and survive. When doctors say a cancer is CD22 positive, they mean the cancer cells—often from B cells—have this protein on their surface.
Why CD22 Positive Can Matter in Cancer Care
Many blood cancers, such as B-cell leukemias and lymphomas, have CD22 on their cancer cells. Knowing whether cancer cells are CD22 positive helps doctors understand the type of cancer and may influence treatment decisions. Some treatments are designed to target CD22, attaching to this protein to deliver medicine directly to cancer cells. This targeted approach aims to kill cancer cells while reducing harm to healthy cells. For example, a drug called Besponsa (inotuzumab ozogamicin) is used to treat certain CD22 positive B-cell acute lymphoblastic leukemia cases, especially when other treatments have not worked.
What Patients Might See or Hear About CD22 Positive
If your cancer is described as CD22 positive, you might hear this term during discussions about diagnosis, treatment options, or clinical trials. It may appear in lab reports, pathology results, or treatment plans. Hearing this term can feel technical or confusing, but it simply means your care team has identified this protein on your cancer cells. This information helps guide treatment choices and may open options for targeted therapies.
What CD22 Positive Does Not Automatically Mean
Being CD22 positive does not by itself describe how aggressive the cancer is or guarantee a particular outcome. It is one piece of information among many that doctors use to understand the cancer. Not all B-cell cancers are CD22 positive, and not all treatments target CD22. CD22 status is part of a broader picture that includes other tests and factors.
Practical Questions to Ask Your Care Team
You might find it helpful to ask your doctor or nurse: What does CD22 positive mean for my cancer type? How does it affect my treatment options? Are there therapies that specifically target CD22? What are the possible benefits and side effects of these treatments? Understanding these points can help you feel more informed and involved in your care decisions.
Understanding CD22 Positive in Context
CD22 positive is a technical term that helps describe your cancer’s biology. It is important to remember that this information is part of your overall diagnosis and treatment plan. Your care team knows your full medical history and test results and can explain what CD22 positive means for you personally. If you hear this term, a good next step is to ask your care team how it fits into your diagnosis and treatment plan. This can help you better understand your care and what to expect.
Safety and Educational Note
This explanation is for education and does not replace personalized medical advice. Every patient’s situation is unique, and only your care team can provide guidance tailored to your health and treatment needs.
Sources
Public source information used for this glossary entry includes: